tert-Butyl (3R)-3-(pyrimidin-4-ylamino)pyrrolidine-1-carboxylate, 1g

2-hydrazinyl-N,N,6-trimethylpyrimidin-4-amine, 95.0%, 1g

(11bS)-4-Hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide, 95.0%, 100g

[(2r,5r)-5-methylpyrrolidin-2-yl]methanol hydrochloride, 98%, 1g

9-Hexadecenoic acid, (9E)-, 250mg

2,4-Dichlorothiazole, 96.0%, 10g

Multi-channel microliter pipette Transferpette® electronic 8-channel, 1 to 20 µl, 1 piece

Trimethyl((tetrahydro-2H-pyran-4-yl)ethynyl)silane, 98%, 100mg

4-cis-[(Boc)2-guanidino]cyclohexane carboxylic acid, 98.0%, 250mg

N,N-Dimethylglycine>98.0%(T)25g

5-(Pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione, 97%, 25mg

5,6-Dihydro-4H-pyrrolo[1,2-b]pyrazole, 95.0%, 250mg

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)ethanone, 95.0%, 5g